Itrakon 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the treatment of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. Itrakon 100 Capsule is administered orally and is well-absorbed, with enhanced bioavailability when taken with food. The dosage and duration of therapy depend on the type and severity of the infection, and treatment should be guided by clinical response and laboratory findings. Caution is advised in patients with hepatic impairment, congestive heart failure, or those receiving concomitant medications that may interact with itraconazole, as it is metabolized by the cytochrome P450 system. Common adverse effects include gastrointestinal disturbances, headache, and rash. Liver function tests should be monitored periodically during prolonged therapy. Itrakon 100 Capsule should be used under medical supervision to ensure appropriate use and to minimize the risk of resistance and adverse effects.

Dosage & How to Use